| Website | quinnova.com |
| Category | BioTech |
| Phone | 215-860-6263 |
| info@quinnova.com | |
| Employees | |
| Founded | 2003 |
| TOTAL | $17.4M |
| FUNDING TOTAL | $17.4M |
| Series B, 11/09 Thomas, McNerney & Partners HIG Ventures Safeguard Scientifics | $17.4M |
Quinnova Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercial sale of prescription drug products based on dermal drug delivery platforms. It offers HYDRO 40 foam, a dry skin treatment product; tersi foam, a leave-on foam indicated for the treatment of seborrheic dermatitis and tinea versicolor; rinnovi nail system, a prescription nail system that is designed to clean, treat, and protect diseased, damaged, brittle, and ingrown nails; and cleanse and treat, a pad delivery technology system for the treatment of acne. Quinnova Pharmaceuticals, Inc. was founded in 2003 and is based in Newtown, Pennsylvania.
